Skip to content

Latest news

AI-Powered Screening Tool Helps Identify People at Higher Risk of Dementia

News

AI-Powered Screening Tool Helps Identify People at Higher Risk of Dementia

An innovative AI-powered screening gatekeeper could help transform how dementia risk is assessed. Researchers from the European PREDICTOM project have developed a risk stratification pipeline that combines established risk factors and cognitive performance data to identify people most likely to benefit from further investigation, helping target costly tests where they are needed most.

Read more
Home-Based Alzheimer's Blood Testing Shows Promise, but Collecting Quality Samples Remains a Challenge

News

Home-Based Alzheimer's Blood Testing Shows Promise, but Collecting Quality Samples Remains a Challenge

Could older adults one day participate in Alzheimer's screening without leaving home? Researchers behind the European PREDICTOM project are exploring that possibility through remote blood collection, but new findings suggest that the biggest hurdle may be getting a good blood sample in the first place.

Read more
🎬 PREDICTOM launches video series exploring the future of early dementia detection

News

🎬 PREDICTOM launches video series exploring the future of early dementia detection

What if Alzheimer's disease could be detected years before symptoms appear? In a newly launched nine-part video series "Predicting Dementia Before It Starts", experts from across PREDICTOM explore how advances in biomarkers, artificial intelligence, brain imaging and digital technologies, and patient involvement could enable earlier and more accurate detection of Alzheimer's disease.

Read more

PREDICTOM Study Progress

This page provides regularly updated information on the progress of the PREDICTOM study for everyone interested in following its development. The tracker will show progress for both Level 1 and Level 2 as the study advances.

Learn more

Our mission

PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.

Learn more